Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials

go back to reference Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 64(24):e139-e228. https://doi.org/10.1016/j.jacc.2014.09.017 CrossRefPubMed Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 64(24):e139-e228. https://​doi.​org/​10.​1016/​j.​jacc.​2014.​09.​017 CrossRefPubMed

go back to reference Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P, Group ESCSD. (2018) 2017 esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177. https://doi.org/10.1093/eurheartj/ehx393 CrossRefPubMed Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P, Group ESCSD. (2018) 2017 esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177. https://​doi.​org/​10.​1093/​eurheartj/​ehx393 CrossRefPubMed

go back to reference O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force on Practice G (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127 (4):e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6 O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force on Practice G (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127 (4):e362-425. https://​doi.​org/​10.​1161/​CIR.​0b013e3182742cf6​

go back to reference Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol C, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J, Management of acute coronary syndromes in patients presenting without persistent STSEotESoC (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37 (3):267–315. https://doi.org/10.1093/eurheartj/ehv320 CrossRefPubMed Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol C, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J, Management of acute coronary syndromes in patients presenting without persistent STSEotESoC (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37 (3):267–315. https://​doi.​org/​10.​1093/​eurheartj/​ehv320 CrossRefPubMed

go back to reference Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Acute C, Urgent Intervention Triage strategy trial I (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet 369 (9565):907–919. https://doi.org/10.1016/S0140-6736(07)60450-4 CrossRefPubMed Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Acute C, Urgent Intervention Triage strategy trial I (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet 369 (9565):907–919. https://​doi.​org/​10.​1016/​S0140-6736(07)60450-4 CrossRefPubMed

go back to reference Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, Investigators H-AT (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Eng J Med 358(21):2218–2230. https://doi.org/10.1056/NEJMoa0708191 CrossRef Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, Investigators H-AT (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Eng J Med 358(21):2218–2230. https://​doi.​org/​10.​1056/​NEJMoa0708191 CrossRef

go back to reference Feldman A, Suleiman K, Bushari L, Yahalom M, Rozner E, Freedberg NA, Turgeman Y (2014) Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients at high risk for bleeding. Int J Angiol 23(4):227–232. https://doi.org/10.1055/s-0034-1372244 CrossRefPubMedPubMedCentral Feldman A, Suleiman K, Bushari L, Yahalom M, Rozner E, Freedberg NA, Turgeman Y (2014) Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients at high risk for bleeding. Int J Angiol 23(4):227–232. https://​doi.​org/​10.​1055/​s-0034-1372244 CrossRefPubMedPubMedCentral

go back to reference Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW, Investigators B (2015) Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. Jama 313(13):1336–1346. https://doi.org/10.1001/jama.2015.2323 CrossRefPubMed Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW, Investigators B (2015) Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. Jama 313(13):1336–1346. https://​doi.​org/​10.​1001/​jama.​2015.​2323 CrossRefPubMed

go back to reference Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M, Laugwitz KL, Pache J, Ott I, Hausleiter J, Seyfarth M, Gick M, Antoniucci D, Schomig A, Berger PB, Mehilli J, Investigators I-RT (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980–1989. https://doi.org/10.1056/NEJMoa1109596 CrossRefPubMed Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M, Laugwitz KL, Pache J, Ott I, Hausleiter J, Seyfarth M, Gick M, Antoniucci D, Schomig A, Berger PB, Mehilli J, Investigators I-RT (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980–1989. https://​doi.​org/​10.​1056/​NEJMoa1109596 CrossRefPubMed

go back to reference Leonardi S, Frigoli E, Rothenbuhler M, Navarese E, Calabro P, Bellotti P, Briguori C, Ferlini M, Cortese B, Lupi A, Lerna S, Zavallonito-Parenti D, Esposito G, Tresoldi S, Zingarelli A, Rigattieri S, Palmieri C, Liso A, Abate F, Zimarino M, Comeglio M, Gabrielli G, Chieffo A, Brugaletta S, Mauro C, Van Mieghem NM, Heg D, Juni P, Windecker S, Valgimigli M, Investigators M (2016) Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. Bmj 354:i4935. https://doi.org/10.1136/bmj.i4935 CrossRefPubMed Leonardi S, Frigoli E, Rothenbuhler M, Navarese E, Calabro P, Bellotti P, Briguori C, Ferlini M, Cortese B, Lupi A, Lerna S, Zavallonito-Parenti D, Esposito G, Tresoldi S, Zingarelli A, Rigattieri S, Palmieri C, Liso A, Abate F, Zimarino M, Comeglio M, Gabrielli G, Chieffo A, Brugaletta S, Mauro C, Van Mieghem NM, Heg D, Juni P, Windecker S, Valgimigli M, Investigators M (2016) Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. Bmj 354:i4935. https://​doi.​org/​10.​1136/​bmj.​i4935 CrossRefPubMed

go back to reference Patti G, Pasceri V, D’Antonio L, D’Ambrosio A, Macri M, Dicuonzo G, Colonna G, Montinaro A, Di Sciascio G (2012) Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the anti-thrombotic strategy for reduction of myocardial damage during angioplasty-bivalirudin vs heparin study). Am J Cardiol 110(4):478–484. https://doi.org/10.1016/j.amjcard.2012.04.017 CrossRefPubMed Patti G, Pasceri V, D’Antonio L, D’Ambrosio A, Macri M, Dicuonzo G, Colonna G, Montinaro A, Di Sciascio G (2012) Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the anti-thrombotic strategy for reduction of myocardial damage during angioplasty-bivalirudin vs heparin study). Am J Cardiol 110(4):478–484. https://​doi.​org/​10.​1016/​j.​amjcard.​2012.​04.​017 CrossRefPubMed

go back to reference Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Tolg R, Anette Fiedler K, Abdel-Wahab M, Kufner S, Schneider S, Schunkert H, Ibrahim T, Mehilli J, Kastrati A, Bavarian Reperfusion Alternatives Evaluation I (2014) Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J 35 (34):2285–2294. https://doi.org/10.1093/eurheartj/ehu182 CrossRefPubMed Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Tolg R, Anette Fiedler K, Abdel-Wahab M, Kufner S, Schneider S, Schunkert H, Ibrahim T, Mehilli J, Kastrati A, Bavarian Reperfusion Alternatives Evaluation I (2014) Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J 35 (34):2285–2294. https://​doi.​org/​10.​1093/​eurheartj/​ehu182 CrossRefPubMed

go back to reference Shahzad A, Kemp I, Mars C, Wilson K, Roome C, Cooper R, Andron M, Appleby C, Fisher M, Khand A, Kunadian B, Mills JD, Morris JL, Morrison WL, Munir S, Palmer ND, Perry RA, Ramsdale DR, Velavan P, Stables RH, Investigators H-Pt (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384 (9957):1849–1858. https://doi.org/10.1016/S0140-6736(14)60924-7 CrossRefPubMed Shahzad A, Kemp I, Mars C, Wilson K, Roome C, Cooper R, Andron M, Appleby C, Fisher M, Khand A, Kunadian B, Mills JD, Morris JL, Morrison WL, Munir S, Palmer ND, Perry RA, Ramsdale DR, Velavan P, Stables RH, Investigators H-Pt (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384 (9957):1849–1858. https://​doi.​org/​10.​1016/​S0140-6736(14)60924-7 CrossRefPubMed

go back to reference Steg PG, van ‘t Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P, Investigators E (2013) Campo dell’. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 369(23):2207–2217. https://doi.org/10.1056/NEJMoa1311096 CrossRefPubMed Steg PG, van ‘t Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P, Investigators E (2013) Campo dell’. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 369(23):2207–2217. https://​doi.​org/​10.​1056/​NEJMoa1311096 CrossRefPubMed

go back to reference Valgimigli M, Frigoli E, Leonardi S, Rothenbuhler M, Gagnor A, Calabro P, Garducci S, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Presbitero P, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabate M, Heg D, Juni P, Vranckx P, Investigators M (2015) Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med 373(11):997–1009. https://doi.org/10.1056/NEJMoa1507854 CrossRefPubMed Valgimigli M, Frigoli E, Leonardi S, Rothenbuhler M, Gagnor A, Calabro P, Garducci S, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Presbitero P, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabate M, Heg D, Juni P, Vranckx P, Investigators M (2015) Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med 373(11):997–1009. https://​doi.​org/​10.​1056/​NEJMoa1507854 CrossRefPubMed

go back to reference Zhang S, Gao W, Li H, Zou M, Sun S, Ba Y, Liu Y, Cheng G (2016) Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol 209:87–95. https://doi.org/10.1016/j.ijcard.2016.01.206 CrossRefPubMed Zhang S, Gao W, Li H, Zou M, Sun S, Ba Y, Liu Y, Cheng G (2016) Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol 209:87–95. https://​doi.​org/​10.​1016/​j.​ijcard.​2016.​01.​206 CrossRefPubMed

go back to reference Cavender MA, Sabatine MS (2014) Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet 384(9943):599–606. https://doi.org/10.1016/S0140-6736(14)61216-2 CrossRefPubMed Cavender MA, Sabatine MS (2014) Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet 384(9943):599–606. https://​doi.​org/​10.​1016/​S0140-6736(14)61216-2 CrossRefPubMed

go back to reference Verdoia M, Schaffer A, Barbieri L, Suryapranata H, De Luca G (2016) Bivalirudin versus unfractionated heparin in acute coronary syndromes: an updated meta-analysis of randomized trials. Revista espanola de cardiologia 69(8):732–745. https://doi.org/10.1016/j.rec.2016.03.007 CrossRefPubMed Verdoia M, Schaffer A, Barbieri L, Suryapranata H, De Luca G (2016) Bivalirudin versus unfractionated heparin in acute coronary syndromes: an updated meta-analysis of randomized trials. Revista espanola de cardiologia 69(8):732–745. https://​doi.​org/​10.​1016/​j.​rec.​2016.​03.​007 CrossRefPubMed

go back to reference Capodanno D, Gargiulo G, Capranzano P, Mehran R, Tamburino C, Stone GW (2016) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 5(3):253–262. https://doi.org/10.1177/2048872615572599 CrossRefPubMed Capodanno D, Gargiulo G, Capranzano P, Mehran R, Tamburino C, Stone GW (2016) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 5(3):253–262. https://​doi.​org/​10.​1177/​2048872615572599​ CrossRefPubMed

go back to reference Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, Swahn E, Henareh L, Wagner H, Hardhammar P, Sjogren I, Stewart J, Grimfjard P, Jensen J, Aasa M, Robertsson L, Lindroos P, Haupt J, Wikstrom H, Ulvenstam A, Bhiladvala P, Lindvall B, Lundin A, Todt T, Ioanes D, Ramunddal T, Kellerth T, Zagozdzon L, Gotberg M, Andersson J, Angeras O, Ostlund O, Lagerqvist B, Held C, Wallentin L, Schersten F, Eriksson P, Koul S, James S (2017) Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med 377(12):1132–1142. https://doi.org/10.1056/NEJMoa1706443 CrossRefPubMed Erlinge D, Omerovic E, Frobert O, Linder R, Danielewicz M, Hamid M, Swahn E, Henareh L, Wagner H, Hardhammar P, Sjogren I, Stewart J, Grimfjard P, Jensen J, Aasa M, Robertsson L, Lindroos P, Haupt J, Wikstrom H, Ulvenstam A, Bhiladvala P, Lindvall B, Lundin A, Todt T, Ioanes D, Ramunddal T, Kellerth T, Zagozdzon L, Gotberg M, Andersson J, Angeras O, Ostlund O, Lagerqvist B, Held C, Wallentin L, Schersten F, Eriksson P, Koul S, James S (2017) Bivalirudin versus heparin monotherapy in myocardial infarction. N Engl J Med 377(12):1132–1142. https://​doi.​org/​10.​1056/​NEJMoa1706443 CrossRefPubMed

go back to reference Pasala T, Gajulapalli RD, Bolen S, Bajaj NS, Gandhi S, Tandar A, Owan T, Welt FG (2016) Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: insights from meta-analysis of randomized and observational studies. Int J Cardiol 221:601–608. https://doi.org/10.1016/j.ijcard.2016.07.043 CrossRefPubMed Pasala T, Gajulapalli RD, Bolen S, Bajaj NS, Gandhi S, Tandar A, Owan T, Welt FG (2016) Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: insights from meta-analysis of randomized and observational studies. Int J Cardiol 221:601–608. https://​doi.​org/​10.​1016/​j.​ijcard.​2016.​07.​043 CrossRefPubMed

go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097 CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://​doi.​org/​10.​1371/​journal.​pmed.​1000097 CrossRefPubMedPubMedCentral

go back to reference He P, Wei H, Wulasihan M, Yang YC, Liu Z, Ma Y, Mei C, Zhang L, Liu T, Wang S, Li L (2016) Comparisons of effectiveness and safety between bivalirudin and heparin with tirofiban in ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Int J Clin Exp Med 9(12):23472–23481 He P, Wei H, Wulasihan M, Yang YC, Liu Z, Ma Y, Mei C, Zhang L, Liu T, Wang S, Li L (2016) Comparisons of effectiveness and safety between bivalirudin and heparin with tirofiban in ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Int J Clin Exp Med 9(12):23472–23481

go back to reference Friedrich JO, Adhikari NK, Beyene J (2007) Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 7:5. https://doi.org/10.1186/1471-2288-7-5 CrossRefPubMedPubMedCentral Friedrich JO, Adhikari NK, Beyene J (2007) Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 7:5. https://​doi.​org/​10.​1186/​1471-2288-7-5 CrossRefPubMedPubMedCentral

go back to reference DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controll Clin Trials 7(3):177–188CrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controll Clin Trials 7(3):177–188CrossRef

go back to reference Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP, National Cardiovascular Data R (2013) Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. Jama 309 (10):1022–1029. https://doi.org/10.1001/jama.2013.1556 CrossRefPubMed Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP, National Cardiovascular Data R (2013) Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. Jama 309 (10):1022–1029. https://​doi.​org/​10.​1001/​jama.​2013.​1556 CrossRefPubMed

go back to reference Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, Kastrati A (2008) Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51(7):690–697. https://doi.org/10.1016/j.jacc.2007.10.040 CrossRefPubMed Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, Kastrati A (2008) Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51(7):690–697. https://​doi.​org/​10.​1016/​j.​jacc.​2007.​10.​040 CrossRefPubMed

go back to reference Tudur Smith C, Marcucci M, Nolan SJ, Iorio A, Sudell M, Riley R, Rovers MM, Williamson PR (2016) Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database Syst Rev 9:MR000007. https://doi.org/10.1002/14651858.MR000007.pub3 PubMedCrossRef Tudur Smith C, Marcucci M, Nolan SJ, Iorio A, Sudell M, Riley R, Rovers MM, Williamson PR (2016) Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database Syst Rev 9:MR000007. https://​doi.​org/​10.​1002/​14651858.​MR000007.​pub3 PubMedCrossRef